机构风向标 | 华森制药(002907)2025年三季度已披露前十大机构持股比例合计下跌1.59个百分点

Core Viewpoint - Huason Pharmaceutical (002907.SZ) reported its Q3 2025 results, highlighting a significant presence of institutional investors holding 41.91% of its total shares, although this represents a decline from the previous quarter [1] Institutional Holdings - As of October 28, 2025, seven institutional investors disclosed holdings in Huason Pharmaceutical, totaling 175 million shares [1] - The institutional investors include Chengdu Local Construction Machinery Engineering Co., Shanghai Tiancheng Investment Management Co., Hong Kong Central Clearing Limited, and several asset management products from Dajia Asset Management and Dajia Life Insurance [1] - The total institutional holding percentage decreased by 1.59 percentage points compared to the previous quarter [1] Public Fund Activity - In this reporting period, 18 public funds were not disclosed compared to the previous quarter, including notable funds such as Bosera Chengyu Economic Circle ETF and Huatai-PB CSI 2000 Index Enhanced A [1] Foreign Investment Trends - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.34% compared to the previous quarter [1] - Barclays Bank PLC was noted as a foreign institution that did not disclose holdings in this period [1]